RED ROCK RESOURCES PLC
RRR | IL
Overview
Corporate Details
- ISIN(s):
- GB00BYWKBV38
- LEI:
- 213800383CFWX3U42W09
- Country:
- United Kingdom
- Address:
- 71-91 ALDWYCH HOUSE, WC2B 4HN LONDON
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Health Care Technology
Description
Renalytix aims to eradicate kidney disease. Its core offering, KidneyIntelX, predicts kidney function decline risk in type 2 diabetics.Ê FDA-approved and covered by Medicare, it improves patient outcomes and resource allocation.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-15 09:04 |
Transaction in Own Shares
Issue of Equity and Warrants and update on DRC
|
English | 13.5 KB | |
| 2025-05-02 14:58 |
Share Issue/Capital Change
Issue of Shares
|
English | 12.1 KB | |
| 2025-04-29 19:28 |
Declaration of Voting Results & Voting Rights Announcements
Share issue under SIP, Directors' dealings and TVR
|
English | 64.0 KB | |
| 2025-02-25 18:46 |
Share Issue/Capital Change
Issue of Equity, Total Voting Rights
|
English | 13.6 KB | |
| 2025-02-19 19:05 |
Regulatory News Service
Update on DRC proceedings
|
English | 10.3 KB | |
| 2025-02-04 13:24 |
Major Shareholding Notification
Holding(s) in Company
|
English | 32.2 KB | |
| 2025-01-31 12:45 |
Share Issue/Capital Change
Issue of Shares and Warrants
|
English | 14.1 KB | |
| 2025-01-29 17:17 |
Capital/Financing Update
DRC Update, Equity Issue, Convertible extension
|
English | 16.2 KB | |
| 2025-01-24 09:00 |
Inside Information Statement
Follow up - DRC Arbitration
|
English | 10.9 KB | |
| 2025-01-23 15:13 |
Major Shareholding Notification
Holding(s) in Company
|
English | 28.6 KB | |
| 2025-01-21 15:12 |
Major Shareholding Notification
Holding(s) in Company
|
English | 29.8 KB | |
| 2025-01-15 14:04 |
Inside Information Statement
Follow up - DRC
|
English | 11.1 KB | |
| 2024-12-31 11:42 |
Declaration of Voting Results & Voting Rights Announcements
Issue of Shares and Warrants, Total Voting Rights
|
English | 13.0 KB | |
| 2024-12-13 14:52 |
Annual Report
Final Results
|
English | 1013.9 KB | |
| 2024-12-11 08:50 |
Regulatory News Service
Update – Australian Gold Project
|
English | 13.3 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Deversify Health AB | Sweden | DEV | |
|
Diagonal Bio AB | Sweden | DIABIO | |
| EDX Medical Group Plc | United Kingdom | N/A | ||
|
Elekta | Sweden | EKTA | |
|
Elos Medtech | Sweden | ELOS | |
|
Episurf | Sweden | EPIS | |
|
FluoGuide A/S | Denmark | FLUO | |
|
GELION PLC | United Kingdom | GELN | |
|
Genetic Analysis AS | Norway | GEAN | |
|
Genomed Spolka Akcyjna | Poland | GEN |